Company InNexus Biotechnology, Inc. Other OTC
Equities
IXSBF
CA45771Q1046
Biotechnology & Medical Research
Business Summary
Sales per Business
USD in Million | 2009 | Weight | 2010 | Weight | Delta |
---|---|---|---|---|---|
Drug Development
nan
%
| 0 | nan % | 0 | nan % | +-NaN% |
Sales per region
USD in Million | 2009 | Weight | 2010 | Weight | Delta |
---|---|---|---|---|---|
Canada
nan
%
| 0 | nan % | 0 | nan % | +-NaN% |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 3,325 | 0 | 0 | 92.40 % |
Stock B | 1 | 163,201,977 | 150,799,507 ( 92.40 %) | 0 | |
Stock C | 0 | 467,188 | 0 | 0 |
Company contact information
InNexus Biotechnology, Inc.
1500 Royal Centre 1055 West Georgia Street
V6E 4N7, Vancouver
+
Sector
1st Jan change | Capi. | |
---|---|---|
+9.83% | 115B | |
+10.80% | 105B | |
-10.84% | 22.71B | |
-1.51% | 21.83B | |
-10.67% | 18.18B | |
-41.92% | 16.52B | |
-15.11% | 16.01B | |
+6.62% | 14.14B | |
+17.53% | 10.71B |